Your smartwatch could warn you about COVID-19
A new algorithm could one day notify smartwatch wearers of stress, capturing events such as air travel, extended exercise, and illness—including COVID-19.
Stay updated with breaking news from Flu Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new algorithm could one day notify smartwatch wearers of stress, capturing events such as air travel, extended exercise, and illness—including COVID-19.
The Philly Vax Sweepstakes awarded 12 cash prizes to city residents after the first drawing was held on June 21. Two people received $50,000 prizes for getting their COVID-19 vaccination. The second drawing, which will include another 12 cash prizes, will be held July 6. The third and final drawing will be on July 19.
email article Since the early days of the pandemic, researchers have been trying to use old drugs for new tricks, raising hopes and spurring controversy. Some of these, like hydroxychloroquine, turned out to be flops, while others are still debated. Recently, another old drug called fluvoxamine has come onto the scene. MedPage Today explores how the old antidepressant has made its way to the COVID spotlight. Fluvoxamine and the COVID Early Treatment Fund Fluvoxamine is the poster child of the COVID-19 Early Treatment Fund (CETF). According to its founder, serial tech entrepreneur Steve...
1 year into COVID: What we wish we’d known 4 takeaways we wish we’d known from day 1 Frank McGeorge, MD, Local 4's Good Health Medical Expert Updated: Tags: READ: READ: Ad From the start, health experts believed the SARS-CoV-2 virus would act similar to the previous coronaviruses that caused SARS and MERS. Experts estimate that about half of all COVID cases are spread by people who are asymptomatic or presymptomatic. At first, masks were only recommended for those who were sick, but numerous studies have now shown that well-fitting fabric masks can effectively prevent spread if we a...
Early last year, Angela Reiersen, a psychiatrist at Washington University in St. Louis, took ill with what she suspected was COVID-19. Because of a shortage of tests at the time, she never found out for sure, and she recovered before long. But the experience got her thinking about something. Reiersen had recently seen research suggesting that an antidepressant called fluvoxamine was useful in treating sepsis, a potentially fatal condition in which the body releases a dangerous imbalance of chemicals known as cytokines into the bloodstream in response to an infection. Might fluvoxamine also be...